PMC:7600245 / 34856-36048
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T135 | 85-88 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T136 | 674-679 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T137 | 708-713 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T138 | 732-741 | Body_part | denotes | monocytes | http://purl.org/sig/ont/fma/fma62864 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T129 | 469-477 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T130 | 478-487 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T131 | 652-660 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T132 | 1123-1131 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T313 | 635-643 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T314 | 666-679 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T315 | 681-686 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T316 | 687-697 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T317 | 708-713 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T318 | 715-719 | http://purl.obolibrary.org/obo/CLO_0001601 | denotes | A549 |
T319 | 715-719 | http://purl.obolibrary.org/obo/CLO_0050025 | denotes | A549 |
T320 | 715-719 | http://purl.obolibrary.org/obo/CLO_0054264 | denotes | A549 |
T321 | 715-719 | http://purl.obolibrary.org/obo/CLO_0054265 | denotes | A549 |
T322 | 715-719 | http://purl.obolibrary.org/obo/CLO_0054266 | denotes | A549 |
T323 | 715-719 | http://purl.obolibrary.org/obo/CLO_0054267 | denotes | A549 |
T324 | 715-719 | http://purl.obolibrary.org/obo/CLO_0054268 | denotes | A549 |
T325 | 715-719 | http://purl.obolibrary.org/obo/CLO_0054269 | denotes | A549 |
T326 | 726-731 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T327 | 732-741 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocytes |
T328 | 782-785 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T329 | 978-983 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T330 | 1039-1040 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T331 | 1098-1099 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T332 | 1144-1145 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T527 | 48-52 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T528 | 91-100 | Chemical | denotes | aspartate | http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314 |
T531 | 230-240 | Chemical | denotes | cobicistat | http://purl.obolibrary.org/obo/CHEBI_72291 |
T532 | 387-389 | Chemical | denotes | NA | http://purl.obolibrary.org/obo/CHEBI_33696 |
T533 | 395-416 | Chemical | denotes | neuroprotective agent | http://purl.obolibrary.org/obo/CHEBI_63726 |
T534 | 434-447 | Chemical | denotes | dexamethasone | http://purl.obolibrary.org/obo/CHEBI_41879 |
T535 | 532-541 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T536 | 569-573 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T537 | 603-612 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T538 | 771-781 | Chemical | denotes | atazanavir | http://purl.obolibrary.org/obo/CHEBI_37924 |
T539 | 805-814 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T540 | 828-832 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T541 | 904-913 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T542 | 939-948 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T543 | 954-958 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T544 | 1007-1009 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T546 | 1071-1081 | Chemical | denotes | atazanavir | http://purl.obolibrary.org/obo/CHEBI_37924 |
T547 | 1110-1119 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T548 | 1172-1185 | Chemical | denotes | nucleic acids | http://purl.obolibrary.org/obo/CHEBI_33696 |
T549 | 1180-1185 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T256 | 0-110 | Sentence | denotes | Atazanavir (Figure 6) is another antiretroviral drug that competitively inhibits the HIV-1 aspartate protease. |
T257 | 111-154 | Sentence | denotes | Atazanavir was approved in 2003 by the U.S. |
T258 | 155-301 | Sentence | denotes | FDA and usually prescribed in combination with the pharmacokinetic booster cobicistat (combination is being marketed under the name Evotaz; 2015). |
T259 | 302-564 | Sentence | denotes | Currently, it is being evaluated alone (NCT04468087; n = 189) or in combination with NA-831 (neuroprotective agent; traneurocin) or dexamethasone for the treatment of COVID-19 infection (NCT04452565; n = 525) or with nitazoxanide/ritonavir (NCT04459286; n = 98). |
T260 | 565-752 | Sentence | denotes | The drug alone or in combination with ritonavir demonstrated in vitro activity against SARS-CoV-2 in Vero E6 cells, human epithelial pulmonary cells (A549), and human monocytes [109,110]. |
T261 | 753-823 | Sentence | denotes | In these studies, atazanavir has been identified as inhibitor of Mpro. |
T262 | 824-949 | Sentence | denotes | The drug and its combination have been projected to be 10-fold more potent than lopinavir and its combination with ritonavir. |
T263 | 950-1035 | Sentence | denotes | The drug also inhibited the virus-induced enhancement of IL-6 and TNF-α levels [109]. |
T264 | 1036-1192 | Sentence | denotes | In a separate computational study, atazanavir was reported as a potential inhibitor of SARS-CoV-2 helicase, a viral enzyme that unwinds nucleic acids [111]. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1052 | 1007-1011 | Gene | denotes | IL-6 | Gene:3569 |
1053 | 1016-1021 | Gene | denotes | TNF-α | Gene:7124 |
1054 | 818-822 | Gene | denotes | Mpro | Gene:8673700 |
1055 | 85-90 | Species | denotes | HIV-1 | Tax:11676 |
1056 | 652-662 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1057 | 681-686 | Species | denotes | human | Tax:9606 |
1058 | 726-731 | Species | denotes | human | Tax:9606 |
1059 | 1123-1133 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
1060 | 0-10 | Chemical | denotes | Atazanavir | MESH:D000069446 |
1061 | 91-100 | Chemical | denotes | aspartate | MESH:D001224 |
1062 | 111-121 | Chemical | denotes | Atazanavir | MESH:D000069446 |
1063 | 230-240 | Chemical | denotes | cobicistat | MESH:D000069547 |
1064 | 287-293 | Chemical | denotes | Evotaz | |
1065 | 387-393 | Chemical | denotes | NA-831 | |
1066 | 418-429 | Chemical | denotes | traneurocin | |
1067 | 434-447 | Chemical | denotes | dexamethasone | MESH:D003907 |
1068 | 519-541 | Chemical | denotes | nitazoxanide/ritonavir | |
1069 | 603-612 | Chemical | denotes | ritonavir | MESH:D019438 |
1070 | 771-781 | Chemical | denotes | atazanavir | MESH:D000069446 |
1071 | 904-913 | Chemical | denotes | lopinavir | MESH:D061466 |
1072 | 939-948 | Chemical | denotes | ritonavir | MESH:D019438 |
1073 | 1071-1081 | Chemical | denotes | atazanavir | MESH:D000069446 |
1074 | 469-477 | Disease | denotes | COVID-19 | MESH:C000657245 |
1075 | 478-487 | Disease | denotes | infection | MESH:D007239 |
1076 | 671-673 | CellLine | denotes | E6 | CVCL:4582 |
1077 | 715-719 | CellLine | denotes | A549 | CVCL:0023 |